Immuron (IMRN) said Friday it has signed an exclusive distribution agreement with Sweden's Calmino Group to launch PROIBS, a digestive-health medical device used for abdominal pain and bloating.
Financial details weren't disclosed.
Immuron shares jumped 50% in Friday trading as intraday volume topped 108.1 million shares, compared with the daily average of 33,558.
Price: 1.67, Change: +0.56, Percent Change: +50.45